Galectin Therapeutics Inc (GALT)
3.34
-0.03
(-0.89%)
USD |
NASDAQ |
May 03, 16:00
3.36
+0.02
(+0.60%)
After-Hours: 20:00
Galectin Therapeutics Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | 0.001M |
September 30, 2021 | 0.00 |
June 30, 2021 | -6.815M |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | -0.044M |
March 31, 2020 | -0.219M |
December 31, 2019 | -0.902M |
September 30, 2019 | -0.163M |
June 30, 2019 | -47.40M |
March 31, 2019 | -2.003M |
December 31, 2018 | -0.124M |
September 30, 2018 | -1.216M |
June 30, 2018 | -9.588M |
March 31, 2018 | -4.451M |
December 31, 2017 | 0.001M |
September 30, 2017 | -0.954M |
June 30, 2017 | -0.485M |
March 31, 2017 | -2.145M |
December 31, 2016 | -5.668M |
September 30, 2016 | 0.00 |
June 30, 2016 | -0.257M |
March 31, 2016 | 0.00 |
December 31, 2015 | -9.128M |
Date | Value |
---|---|
September 30, 2015 | -0.041M |
June 30, 2015 | 0.00 |
March 31, 2015 | -4.532M |
December 31, 2014 | -1.099M |
September 30, 2014 | -0.06M |
June 30, 2014 | 0.00 |
March 31, 2014 | -28.18M |
December 31, 2013 | -0.833M |
September 30, 2013 | -3.00M |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | -10.40M |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 | |
December 31, 2010 | |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 | |
December 31, 2009 | |
September 30, 2009 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-47.40M
Minimum
Jun 2019
0.001M
Maximum
Dec 2021
-5.049M
Average
-0.044M
Median
Jun 2020
Stock Buybacks (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | -235.70M |
Viking Therapeutics Inc | -597.12M |
89bio Inc | -162.66M |
Terns Pharmaceuticals Inc | -13.69M |
Enanta Pharmaceuticals Inc | -- |